Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Eman S. Shalaby, Sally Aboutaleb, Shaymaa A. Ismail, Noha N. Yassen & Ahmed A. Sedik. (2023) Chitosan tamarind-based nanoparticles as a promising approach for topical application of curcumin intended for burn healing: in vitro and in vivo study. Journal of Drug Targeting 31:10, pages 1081-1097.
Read now
Read now
Peipei Xu, Ruju Wang, Xiaohui Wang & Jian Ouyang. (2016) Recent advancements in erythrocytes, platelets, and albumin as delivery systems. OncoTargets and Therapy 9, pages 2873-2884.
Read now
Read now
Mahdi Karimi, Sajad Bahrami, Soodeh Baghaee Ravari, Parham Sahandi Zangabad, Hamed Mirshekari, Mahnaz Bozorgomid, Somayeh Shahreza, Masume Sori & Michael R. Hamblin. (2016) Albumin nanostructures as advanced drug delivery systems. Expert Opinion on Drug Delivery 13:11, pages 1609-1623.
Read now
Read now
Donna V. Peralta, Jibao He, Damon A. Wheeler, Jin Z. Zhang & Matthew A. Tarr. (2014) Encapsulating gold nanomaterials into size-controlled human serum albumin nanoparticles for cancer therapy platforms. Journal of Microencapsulation 31:8, pages 824-831.
Read now
Read now
Sebastian Gaca, Sebastian Reichert, Claus Rödel, Franz Rödel & Jörg Kreuter. (2012) Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells. Journal of Microencapsulation 29:7, pages 685-694.
Read now
Read now
Articles from other publishers (35)
Xinhao Xu, Jinyu Hu, Huaqian Xue, Yingying Hu, Ya-nan Liu, Guanyang Lin, Liangle Liu & Ren-ai Xu. (2023) Applications of human and bovine serum albumins in biomedical engineering: A review. International Journal of Biological Macromolecules 253, pages 126914.
Crossref
Crossref
Eliska Prchalova, Zuzana Kohoutova, Karolina Knittelova, David Malinak & Kamil Musilek. (2023) Strategies for enhanced bioavailability of oxime reactivators in the central nervous system. Archives of Toxicology 97:11, pages 2839-2860.
Crossref
Crossref
Leysan Vasileva, Gulnara Gaynanova, Irina Zueva, Anna Lyubina, Syumbelya Amerhanova, Daina Buzyurova, Vasily Babaev, Alexandra Voloshina, Konstantin Petrov & Lucia Zakharova. (2022) Transdermal Delivery of 2-PAM as a Tool to Increase the Effectiveness of Traditional Treatment of Organophosphate Poisoning. International Journal of Molecular Sciences 23:23, pages 14992.
Crossref
Crossref
Karolina Kulig, Magdalena Ziąbka, Kacper Pilarczyk, Aleksandra Owczarzy, Wojciech Rogóż & Małgorzata Maciążek-Jurczyk. (2022) Physicochemical Study of Albumin Nanoparticles with Chlorambucil. Processes 10:6, pages 1170.
Crossref
Crossref
B. Kharazian, A.A. Ahmad & A. Mabudi. (2021) A molecular dynamics study on the binding of gemcitabine to human serum albumin. Journal of Molecular Liquids 337, pages 116496.
Crossref
Crossref
Wei Huang, Gao Xiao, Yujuan Zhang & Weiping Min. (2021) Research progress and application opportunities of nanoparticle–protein corona complexes. Biomedicine & Pharmacotherapy 139, pages 111541.
Crossref
Crossref
Sermet Sezigen, Ozgur Esim, Meral Sarper & Ayhan Savaser. (2020) In vitro evaluation of two different types of obidoxime-loaded nanoparticles for cytotoxicity and blood-brain barrier transport. Toxicology Letters 330, pages 53-58.
Crossref
Crossref
Yerkeblan Tazhbayev, Olzhas Mukashev, Meiram Burkeyev & Vladimir I. Lozinsky. (2020) Synthesis and Comparative Study of Nanoparticles Derived from Bovine and Human Serum Albumins. Polymers 12:6, pages 1301.
Crossref
Crossref
Fatemeh Jahansooz, Bahman Ebrahimi Hosseinzade, Ashrafalsadat Hatamian Zarmi, Fatemeh Hadi, Seyed Mohammad Massood Hojjati & Koorosh Shahpasand. (2020) Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson’s animal models. Therapeutic Delivery 11:6, pages 387-399.
Crossref
Crossref
Maie S. Taha, Smrithi Padmakumar, Amit Singh & Mansoor M. Amiji. (2020) Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation. Drug Delivery and Translational Research 10:3, pages 766-790.
Crossref
Crossref
Mohd Nor Faiz Norrrahim, Mas Amira Idayu Abdul Razak, Noor Aisyah Ahmad Shah, Herdawati Kasim, Wan Yusmawati Wan Yusoff, Norhana Abdul Halim, Siti Aminah Mohd Nor, Siti Hasnawati Jamal, Keat Khim Ong, Wan Md Zin Wan Yunus, Victor Feizal Knight & Noor Azilah Mohd Kasim. (2020) Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review. RSC Advances 10:8, pages 4465-4489.
Crossref
Crossref
Sina Parvaz, Reza Taheri-Ledari, Mir Saeed Esmaeili, Mahboubeh Rabbani & Ali Maleki. (2020) A brief survey on the advanced brain drug administration by nanoscale carriers: With a particular focus on AChE reactivators. Life Sciences 240, pages 117099.
Crossref
Crossref
Mariana Azevedo Rosa, Henrique Dipe De Faria, Diailison Teixeira Carvalho & Eduardo Costa Figueiredo. (2019) Biological sample preparation by using restricted-access nanoparticles prepared from bovine serum albumin: application to liquid chromatographic determination of β-blockers. Microchimica Acta 186:9.
Crossref
Crossref
Tazhbayev, Mukashev, Burkeev & Kreuter. (2019) Hydroxyurea-Loaded Albumin Nanoparticles: Preparation, Characterization, and In Vitro Studies. Pharmaceutics 11:8, pages 410.
Crossref
Crossref
Amelie Heuer-JungemannNeus Feliu, Ioanna BakaimiMajd Hamaly, Alaaldin Alkilany, Indranath Chakraborty, Atif Masood, Maria F. Casula, Athanasia Kostopoulou, Eunkeu Oh, Kimihiro Susumu, Michael H. Stewart, Igor L. Medintz, Emmanuel Stratakis, Wolfgang J. Parak & Antonios G. Kanaras. (2019) The Role of Ligands in the Chemical Synthesis and Applications of Inorganic Nanoparticles. Chemical Reviews 119:8, pages 4819-4880.
Crossref
Crossref
Zvezdelina Yaneva & Nedyalka Georgieva. 2018. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology
173
218
.
Mikhail V. Zyuzin, Yan Yan, Raimo Hartmann, Katelyn T. Gause, Moritz Nazarenus, Jiwei Cui, Frank Caruso & Wolfgang J. Parak. (2017) Role of the Protein Corona Derived from Human Plasma in Cellular Interactions between Nanoporous Human Serum Albumin Particles and Endothelial Cells. Bioconjugate Chemistry 28:8, pages 2062-2068.
Crossref
Crossref
Bharat Bhushan, Vitaly Khanadeev, Boris Khlebtsov, Nikolai Khlebtsov & P. Gopinath. (2017) Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery. Advances in Colloid and Interface Science 246, pages 13-39.
Crossref
Crossref
Himadri B. Bohidar & Kamla Rawat. 2017. Design of Nanostructures. Design of Nanostructures
293
324
.
Tatiana N. Pashirova, Irina V. Zueva, Konstantin A. Petrov, Vasily M. Babaev, Svetlana S. Lukashenko, Ildar Kh. Rizvanov, Eliana B. Souto, Evgeny E. Nikolsky, Lucia Ya. Zakharova, Patrick Masson & Oleg G. Sinyashin. (2017) Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity. ACS Applied Materials & Interfaces 9:20, pages 16922-16932.
Crossref
Crossref
Lin Wu, Mingyu Chen, Huijuan Mao, Ningning Wang, Bo Zhang, Xiufen Zhao, Jun Qian & Changying Xing. (2017) Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes. International Journal of Molecular Medicine 39:4, pages 851-860.
Crossref
Crossref
Jun Yang, Lixue Fan, Feijian Wang, Yuan Luo, Xin Sui, Wanhua Li, Xiaohong Zhang & Yongan Wang. (2016) Rapid-releasing of HI-6 via brain-targeted mesoporous silica nanoparticles for nerve agent detoxification. Nanoscale 8:18, pages 9537-9547.
Crossref
Crossref
Sara Salatin, Mitra Jelvehgari, Solmaz Maleki-Dizaj & Khosro Adibkia. (2015) A sight on protein-based nanoparticles as drug/gene delivery systems. Therapeutic Delivery 6:8, pages 1017-1029.
Crossref
Crossref
Hossein Mohammad-Beigi, Seyed Abbas Shojaosadati, Dina Morshedi, Ayyoob Arpanaei & Amir Tayaranian Marvian. (2015) Preparation and in vitro characterization of gallic acid-loaded human serum albumin nanoparticles. Journal of Nanoparticle Research 17:4.
Crossref
Crossref
H. Kalász, S. M. Nurulain, G. Veress, S. Antus, F. Darvas, E. Adeghate, A. Adem, F. Hashemi & K. Tekes. (2015) Mini review on blood-brain barrier penetration of pyridinium aldoximes. Journal of Applied Toxicology 35:2, pages 116-123.
Crossref
Crossref
Mehmet Emin Çorman, Canan Armutcu, Serpil Özkara, Lokman Uzun & Adil Denizli. (2015) Molecularly imprinted cryogel cartridges for the specific filtration and rapid separation of interferon alpha. RSC Advances 5:56, pages 45015-45026.
Crossref
Crossref
Hasan Kouchakzadeh, Maryam Sadat Safavi & Seyed Abbas Shojaosadati. 2015. Protein and Peptide Nanoparticles for Drug Delivery. Protein and Peptide Nanoparticles for Drug Delivery
121
143
.
Matthias G Wacker, Mahmut Altinok, Stephan Urfels & Johann Bauer. (2014) Nanoencapsulation of ultra-small superparamagnetic particles of iron oxide into human serum albumin nanoparticles. Beilstein Journal of Nanotechnology 5, pages 2259-2266.
Crossref
Crossref
M.Zh. Burkeev, J. Kreuter, A.M. Herk, Y.M. Tazhbayev, L.Zh. Zhaparova, T.S. Zhumagalieva & N.K. Zhappar. (2014) Nanoencapsulation of Antitumor and Antituberculosis Drug Preparations with Biocompatible Polymers. Journal of Research Updates in Polymer Science 3:2, pages 63-85.
Crossref
Crossref
Sebastian Gaca, Sebastian Reichert, Gabriele Multhoff, Matthias Wacker, Stephanie Hehlgans, Claus Botzler, Matthias Gehrmann, Claus Rödel, Jörg Kreuter & Franz Rödel. (2013) Targeting by cmHsp70.1-antibody coated and survivin miRNA plasmid loaded nanoparticles to radiosensitize glioblastoma cells. Journal of Controlled Release 172:1, pages 201-206.
Crossref
Crossref
James Chen Yong Kah, John Chen, Angel Zubieta & Kimberly Hamad-Schifferli. (2012) Exploiting the Protein Corona around Gold Nanorods for Loading and Triggered Release. ACS Nano 6:8, pages 6730-6740.
Crossref
Crossref
Ahmed O. Elzoghby, Wael M. Samy & Nazik A. Elgindy. (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release 157:2, pages 168-182.
Crossref
Crossref
Miriam Dadparvar, Sylvia Wagner, Sascha Wien, Jürgen Kufleitner, Franz Worek, Hagen von Briesen & Jörg Kreuter. (2011) HI 6 human serum albumin nanoparticles—Development and transport over an in vitro blood–brain barrier model. Toxicology Letters 206:1, pages 60-66.
Crossref
Crossref
Stefanie Wohlfart, Alexander S. Khalansky, Christian Bernreuther, Martin Michaelis, Jindrich CinatlJr.Jr., Markus Glatzel & Jörg Kreuter. (2011) Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles. International Journal of Pharmaceutics 415:1-2, pages 244-251.
Crossref
Crossref
Matthias Wacker, Anja Zensi, Jürgen Kufleitner, Aaron Ruff, Jessica Schütz, Tobias Stockburger, Thomas Marstaller & Vitali Vogel. (2011) A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation. International Journal of Pharmaceutics 414:1-2, pages 225-232.
Crossref
Crossref